Bruker logo

BRKR - Bruker Share Price

$53.63 -0.4  -0.7%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £6.36bn
Enterprise Value £6.55bn
Revenue £1.55bn
Position in Universe 900th / 6416
Bullish
Bearish
Unlock BRKR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BRKR Revenue Unlock BRKR Revenue

Net Income

BRKR Net Income Unlock BRKR Revenue

Normalised EPS

BRKR Normalised EPS Unlock BRKR Revenue

PE Ratio Range

BRKR PE Ratio Range Unlock BRKR Revenue

Dividend Yield Range

BRKR Dividend Yield Range Unlock BRKR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BRKR EPS Forecasts Unlock BRKR Revenue
Profile Summary

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated February 4, 2000
Public Since August 4, 2000
No. of Shareholders: 79
No. of Employees: 6,870
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 153,991,644
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BRKR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BRKR
Upcoming Events for BRKR
Similar to BRKR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.